Gastro Medical News about Inflammatory Bowel Diseases

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

High and Low Vitamin A Therapies Induce Distinct FoxP3+ T-Cell Subsets and Effectively Control Intestinal Inflammation
Gastroenterology, 10/07/09

Kang SG et al. – The authors' results identify novel pathways of inducing highly suppressive FoxP3+ regulatory T cells that can effectively control intestinal inflammation. The results have significant ramifications in treating inflammatory bowel diseases.

<< Previous
Intraoperative blood salvage and leukocyte depletion during liver...

Next >>
Incidence and mortality by colorectal cancer in Spain during...